BlossomHill Therapeutics closed $100 million in a Series B financing led by Colt Ventures to advance its pipeline of in-house discovery and development programs for multiple high-need cancers and autoimmune diseases.
Amount Raised
$100 Million
Round Type
Series B
San DiegoBiotechnologyHealthcareHealth CareInvestors
Description
BlossomHill Therapeutics announced the closing of a $100 million Series B financing round led by Colt Ventures, with participation from new and existing investors such as Cormorant Asset Management, OrbiMed, Vivo Capital, Hercules BioVentures Partners LLC, Plaisance Capital Management LLC and H&D Asset Management, among others. The company plans to use the proceeds to advance its pipeline of multiple in-house discovery and development programs for multiple high-need cancers and autoimmune diseases into the clinic.
Quick answer
BlossomHill Therapeutics raised $100 Million in a Series B round, dated February 29, 2024. Investors: H&D Asset Management, Plaisance Capital Management LLC, Hercules Bio Ventures Partners Llc, Vivo Capital, Orbi Med, Cormorant Asset Management and Colt Ventures. BlossomHill Therapeutics is based in San Diego, California, United States.
- How much did BlossomHill Therapeutics raise?
- BlossomHill Therapeutics raised $100 Million in a Series B round on February 29, 2024.
- Who invested in BlossomHill Therapeutics?
- H&D Asset Management, Plaisance Capital Management LLC, Hercules Bio Ventures Partners Llc, Vivo Capital, Orbi Med, Cormorant Asset Management and Colt Ventures are named as investors in this round.
- What does BlossomHill Therapeutics do?
- BlossomHill Therapeutics, Inc. is a small molecule drug discovery and development company focused on unmet medical needs in oncology and autoimmune disorders.
- Where is BlossomHill Therapeutics based and how big is it?
- BlossomHill Therapeutics is based in San Diego, California, United States. Fundz records about 70 employees.
- Who are the decision-makers at BlossomHill Therapeutics?
- Fundz holds 1 contact at BlossomHill Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at BlossomHill Therapeutics, and when
A new round usually means BlossomHill Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day BlossomHill Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at BlossomHill Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BlossomHill Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BlossomHill Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansBlossomHill Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.